The University of Florida’s Pulmonary, Critical Care, Lung Transplant, and Thoracic Programs form one of the nation’s premier destinations for complex lung and airway disease. As a high-volume referral center, UF provides advanced care for patients with the most challenging medical and surgical needs, including highly HLA-sensitized individuals, those requiring ECMO support, patients with multi-organ dysfunction, and adults or children needing lung or multi-organ transplantation. UF’s Pulmonary Vascular Disease Center and Rare Lung Disease Program delivers nationally recognized expertise across pulmonary arterial hypertension, hereditary hemorrhagic telangiectasia, lymphangioleiomyomatosis, and pulmonary alveolar proteinosis, each supported by accreditation as a Center of Excellence from leading national foundations. Integrated closely with thoracic surgery and cutting-edge research teams, these programs collectively drive innovation in diagnosis, therapeutics, and multidisciplinary care, establishing UF as a leading hub for advanced lung disease and transformative respiratory medicine.
Strados Labs
Strados Labs is a medical technology company focused on improving the lives of patients with respiratory diseases. Enabling remote monitoring of lung health, Strados Labs’ RESP Biosensor allows clinicians to continuously measure patients’ lung sounds such as cough and wheeze that can indicate an exacerbation or reduced quality of life. The technology is used to assist drug developers in demonstrating treatment efficacy in clinical trials and to support clinicians in disease surveillance and management. The RESP Biosensor is FDA-cleared, CE marked and HIPAA compliant, backed by multiple awards and clinical publications. Strados Labs is privately owned and based in Philadelphia, PA.
SeqDiagnostics
SeqDiagnostics is a molecular diagnostics company developing next-generation sequencing (NGS) assays to improve the detection and characterization of respiratory infections. Our flagship assay, NTM-Seq, provides rapid species-level identification and antimicrobial resistance insights for nontuberculous mycobacteria directly from respiratory samples, helping clinicians make more informed treatment decisions.
Praxis Medical LLC
Praxis Medical is committed to developing innovative technologies that address unmet clinical needs to improve the lives of doctors, providers, and most importantly, patients. We are developing EndoCore- the world’s first motorized EBUS fine needle biopsy device. The EndoCore is designed to rotate the EBUS needle at the time of biopsy to harvest more cellular material in fewer passes. *This device is investigational.
PAREXEL
Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ | Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients. We work With HeartTM every day to treat patients with dignity and learn from their experiences, so every trial makes a difference.
NTM Info & Research
NTM Info & Research (NTMir) is a 501(c)(3) non-profit organization formed on behalf of patients with pulmonary nontuberculous mycobacterial (NTM) disease, bronchiectasis, and other related comorbid diseases for patient support, medical education, and research. NTMir’s mission is to save and improve lives by raising awareness, providing education and a broad support network for patients, and catalyzing research to promote early detection, accelerate the development of improved treatments and improve the quality of life for these patients.
National Jewish Health
National Jewish Health is the leading respiratory hospital in the nation. Founded 125 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory and complex diseases. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit njhealth.org.
National Jewish Health Advanced Diagnostic Laboratories
National Jewish Health Advanced Diagnostic Laboratories provides unparalleled expertise in immune and respiratory disease to our clinical, biotech, pharmaceutical, public health and diagnostic partners. Our high complexity, CLIA and CAP15189-certified laboratories have decades of experience developing immunology, complement, infectious disease and molecular genomic tests. Our world-renowned scientists are committed to providing the highest quality specialized laboratory services. Visit us at Booth 1026 to learn about our TRIKAFTKA drug monitoring test, Alpha-1 genomic panel and more. Njlabs.org